Indus Capital Partners Cut Its China Biologic Prods (CBPO) Holding; Southwest Airlines Co (LUV) Has 0.83 Sentiment

December 6, 2017 - By Vivian Currie

Southwest Airlines Co. operates a passenger airline that provides scheduled air transportation services in the United States and near-international markets. The company has market cap of $36.43 billion. As of December 31, 2016, the firm operated a total of 723 Boeing 737 aircraft; and served 101 destinations in 40 states, the District of Columbia, and the Commonwealth of Puerto Rico, as well as 8 near-international countries, including Mexico, Jamaica, The Bahamas, Aruba, the Dominican Republic, Costa Rica, Belize, and Cuba. It has a 18.83 P/E ratio. It also sells frequent flyer points and related services to business partners participating in the Rapid Rewards frequent flyer program, such as car rental agencies, hotels, restaurants, and retailers.

Indus Capital Partners Llc decreased China Biologic Prods Inc (CBPO) stake by 1.47% reported in 2017Q2 SEC filing. Indus Capital Partners Llc sold 4,143 shares as China Biologic Prods Inc (CBPO)’s stock rose 0.78%. The Indus Capital Partners Llc holds 278,407 shares with $31.49 million value, down from 282,550 last quarter. China Biologic Prods Inc now has $2.24B valuation. The stock decreased 0.23% or $0.18 during the last trading session, reaching $81.12. About 84,364 shares traded. China Biologic Products Holdings, Inc. (NASDAQ:CBPO) has declined 1.48% since December 6, 2016 and is downtrending. It has underperformed by 18.18% the S&P500.

Analysts await Southwest Airlines Co. (NYSE:LUV) to report earnings on January, 25. They expect $0.83 earnings per share, up 12.16% or $0.09 from last year’s $0.74 per share. LUV’s profit will be $492.51M for 18.49 P/E if the $0.83 EPS becomes a reality. After $0.88 actual earnings per share reported by Southwest Airlines Co. for the previous quarter, Wall Street now forecasts -5.68% negative EPS growth.

The stock decreased 0.32% or $0.195 during the last trading session, reaching $61.4. About 1.61M shares traded. Southwest Airlines Co. (LUV) has risen 37.63% since December 6, 2016 and is uptrending. It has outperformed by 20.93% the S&P500.

Ratings analysis reveals 100% of Southwest Air’s analysts are positive. Out of 6 Wall Street analysts rating Southwest Air, 6 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $46.0 while the high is $57.0. The stock’s average target of $51.33 is -16.40% below today’s ($61.4) share price. LUV was included in 6 notes of analysts from September 9, 2016. The stock has “Outperform” rating by Bernstein on Tuesday, October 11. Imperial Capital initiated the stock with “Outperform” rating in Friday, September 9 report. The stock of Southwest Airlines Co. (NYSE:LUV) earned “Outperform” rating by Cowen & Co on Friday, January 27. On Friday, November 18 the stock rating was initiated by Citigroup with “Buy”. The stock has “Overweight” rating by Morgan Stanley on Thursday, January 5. The stock of Southwest Airlines Co. (NYSE:LUV) has “Overweight” rating given on Thursday, October 27 by JP Morgan.

Greenbrier Partners Capital Management Llc holds 16.5% of its portfolio in Southwest Airlines Co. for 1.26 million shares. Provident Trust Co owns 2.69 million shares or 8.06% of their US portfolio. Moreover, Gibraltar Capital Management Inc. has 7.31% invested in the company for 117,630 shares. The Texas-based Ray Gerald L & Associates Ltd has invested 7.07% in the stock. Royal Bank Of Scotland Group Plc, a United Kingdom-based fund reported 344,897 shares.

Indus Capital Partners Llc increased Coach Inc (NYSE:COH) stake by 538,624 shares to 1.56 million valued at $73.71 million in 2017Q2. It also upped Valeant Pharmaceuticals Intl (NYSE:VRX) stake by 104,700 shares and now owns 121,500 shares. Alibaba Group Hldg Ltd (NYSE:BABA) was raised too.

Investors sentiment decreased to 0.65 in Q2 2017. Its down 0.37, from 1.02 in 2017Q1. It is negative, as 27 investors sold CBPO shares while 42 reduced holdings. 11 funds opened positions while 34 raised stakes. 15.29 million shares or 21.23% less from 19.41 million shares in 2017Q1 were reported. Sg Americas Securities Ltd Llc holds 0.02% in China Biologic Products Holdings, Inc. (NASDAQ:CBPO) or 17,414 shares. Davidson Kempner Cap Mngmt Limited Partnership holds 0.29% or 110,000 shares. Deutsche Commercial Bank Ag invested 0% in China Biologic Products Holdings, Inc. (NASDAQ:CBPO). Credit Agricole S A invested in 151,101 shares. Axa reported 94,334 shares or 0.05% of all its holdings. Proshare Ltd owns 13,961 shares or 0.02% of their US portfolio. Dekabank Deutsche Girozentrale stated it has 12,730 shares or 0.01% of all its holdings. 12,418 are held by State Street Corporation. Altrinsic Glob Advisors Llc invested 0.17% in China Biologic Products Holdings, Inc. (NASDAQ:CBPO). Artisan Partners Limited Partnership, a Wisconsin-based fund reported 444,439 shares. Vanguard Group owns 23,686 shares for 0% of their portfolio. Manning And Napier Advsrs Ltd Liability Com owns 71,755 shares. Agf Incorporated owns 0.21% invested in China Biologic Products Holdings, Inc. (NASDAQ:CBPO) for 163,920 shares. Ubs Asset Mngmt Americas Inc reported 225,140 shares. Credit Suisse Ag accumulated 4,311 shares or 0% of the stock.

Among 2 analysts covering China Biologic Products (NASDAQ:CBPO), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. China Biologic Products had 6 analyst reports since September 4, 2015 according to SRatingsIntel. The stock has “Buy” rating by Jefferies on Friday, September 4. The stock has “Buy” rating by Jefferies on Tuesday, September 12. The stock of China Biologic Products Holdings, Inc. (NASDAQ:CBPO) has “Buy” rating given on Monday, June 12 by Jefferies. As per Thursday, August 3, the company rating was maintained by Jefferies. The rating was maintained by Jefferies with “Buy” on Friday, October 13.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: